logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Michael A. Nauck

ruhr-university-bochum

110H指数
586论文数
6.6W被引数
收录论文 239
发表时间
logo
Challenging the Consensus Statement: Is It Time to Recognise Pharmacological Remission of Type 2 Diabetes?挑战共识声明：是否该是承认2型糖尿病药物缓解的时候了？
errdiabetes, obesity and metabolism
IF0
err2026-03-19
err0
PREAI
errCristina Bianchi; Stefano Del Prato; Amy E. Rothberg; Michael A. Nauck
err分享
err收藏
Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and Vomiting对于2型糖尿病中使用肠促胰岛素拟似物的剂量递增方案与恶心和呕吐的耐受性相关。
errdiabetes, obesity and metabolism
IF0
err2026-02-27
err0
errOAAI
errMichael A. Nauck; Viktoria Punov; Yu Mi Kang; Soo Lim
err分享
err收藏
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes在2型糖尿病中，替西帕肽与度拉糖肽的心血管结局比较
errNew England Journal of Medicine
IF78.5
err2025-12-18
err12
PREAI
errNicholls, Stephen J.; Pavo, Imre; Bhatt, Deepak L.; Buse, John B.; Del Prato, Stefano; Kahn, Steven E.; Lincoff, A. Michael; McGuire, Darren K.; Miller, Debra; Nauck, Michael A.; Nishiyama, Hiroshi; Nissen, Steven E.; Sattar, Naveed; Weerakkody, Govinda; Wiese, Russell J.; Zinman, Bernard; Zoungas, Sophia; Basile, Jan; Davies, Melanie J.; Giorgino, Francesco; Kellerer, Monika; Ji, Linong; Varkonyi, Tamas; Menon, Venu; Broder, Jonathan C.; Herschtal, Alan; D'Alessio, David
err分享
err收藏
Novel GLP-1-based Medications for Type 2 Diabetes and ObesitySon JW, le Roux CW, Blüher M, Nauck MA, and Lim S. 针对2型糖尿病和肥胖的新型GLP-1基药物。内分泌评论。(2025) 7:bnaf036。doi: 10.1210/endrev/bnaf036
errENDOCRINE REVIEWS
IF22
err2025-10-01
err2
PREAI
errSon, Jang Won; le Roux, Carel W.; Bluher, Matthias; Nauck, Michael A.; Lim, Soo
err分享
err收藏
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover Study二甲双胍对2型糖尿病患者餐后血压、心率、胃排空、GLP-1及餐后低血压患病率的影响：一项双盲、安慰剂对照交叉研究
errDIABETES
IF7.5
err2025-01-06
err0
PREAI
errQuast, Daniel R.; Xie, Cong; Bound, Michelle J.; Grivell, Jacqueline; Hatzinikolas, Seva; Jones, Karen L.; Horowitz, Michael; Rayner, Christopher K.; Nauck, Michael A.; Meier, Juris J.; Phillips, Liza K.; Wu, Tongzhi
err分享
err收藏
Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal MotilityGLP-1-based疗法对胃，胆和肠运动的影响的生理学和药理学
errENDOCRINOLOGY
IF3.3
err2024-11-21
err3
errOAAI
errJalleh, Ryan J.; Marathe, Chinmay S.; Rayner, Christopher K.; Jones, Karen L.; Umapathysivam, Mahesh M.; Wu, Tongzhi; Quast, Daniel R.; Plummer, Mark P.; Nauck, Michael A.; Horowitz, Michael
err分享
err收藏
Cardiovascular outcome with SGLT2i and GLP1RA
errEUROPEAN JOURNAL OF INTERNAL MEDICINE
IF6.1
err2024-11-01
err0
PREAI
errLim, Soo; Sohn, Minji; Nauck, Michael A.
err分享
err收藏
Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and TirzepatideGLP-1受体激动剂和替吉帕特对胃排空延迟的临床后果
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2024-10-17
err3
errOAAI
errJalleh, Ryan J.; Plummer, Mark P.; Marathe, Chinmay S.; Umapathysivam, Mahesh M.; Quast, Daniel R.; Rayner, Christopher K.; Jones, Karen L.; Wu, Tongzhi; Horowitz, Michael; Nauck, Michael A.
err分享
err收藏
Long-term comparison of renal and metabolic outcomes after sodium-glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes
errBMC MEDICINE
IF8.3
err2024-07-02
err1
errOAAI
errSohn, Minji; Nam, Seoungyeon; Nauck, Michael A.; Lim, Soo
err分享
err收藏
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-07-01
err1
errOAAI
errQuast, Daniel R.; Lancaster, Dara; Xie, Cong; Bound, Michelle J.; Grivell, Jacqueline; Jones, Karen L.; Horowitz, Michael; Meier, Juris J.; Wu, Tongzhi; Rayner, Christopher K.; Nauck, Michael A.
err分享
err收藏
Early Sodium-Glucose Cotransporter 2 Inhibitors-Induced Change in Haematocrit as a Predictor of Mortality and Cardiovascular Risk-A Real-World Study
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errToulis, Konstantinos A.; Wang, Jingya; Tan, Luyuan; Nirantharakumar, Krishnarajah; Nauck, Michael A.
err分享
err收藏
Getting the measure of the pressure: Optimal assessment of the effects of glucagon-like peptide-1 receptor agonists on blood pressure
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-05-05
err0
errOAAI
errJones, Karen L.; Marathe, Chinmay S.; Wu, Tongzhi; Rayner, Christopher K.; Nauck, Michael; Horowitz, Michael
err分享
err收藏
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics
errAMERICAN HEART JOURNAL
IF3.5
err2024-01-01
err79
errOAAI
errNicholls, Stephen J.; Bhatt, Deepak L.; Buse, John B.; Del Prato, Stefano; Kahn, Steven E.; Lincoff, A. Michael; McGuire, Darren K.; Nauck, Michael A.; Nissen, Steven E.; Sattar, Naveed; Zinman, Bernard; Zoungas, Sophia; Basile, Jan; Bartee, Amy; Miller, Debra; Nishiyama, Hiroshi; Pavo, Imre; Weerakkody, Govinda; Wiese, Russell J.; D'Alessio, David
err分享
err收藏
Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists在评估胰高血糖素样肽1受体激动剂时准确测量胃排空和胃肠道症状
errANNALS OF INTERNAL MEDICINE
IF15.2
err2023-11-01
err9
PREAI
errJalleh, Ryan J.; Jones, Karen L.; Nauck, Michael; Horowitz, Michael
err分享
err收藏
Non-peptide, once-per-day oral orforglipron to compete with established peptide-based, injectable GLP-1 receptor agonists
errLANCET
IF88.5
err2023-08-01
err2
PREAI
errNauck, Michael A.; Horowitz, Michael
err分享
err收藏
Impact of concomitant oral glucose-lowering medications on the success of basal insulin titration in insulin-naive patients with type 2 diabetes: a systematic analysis
errBMJ OPEN DIABETES RESEARCH & CARE
IF4.1
err2023-07-11
err0
errOAAI
errWollenhaupt, Dominik; Wolters, Jannik; Abd El Aziz, Mirna; Nauck, Michael A.
err分享
err收藏
Incretin hormones and type 2 diabetes
errDIABETOLOGIA
IF10.2
err2023-07-11
err47
errOAAI
errNauck, Michael A.; Mueller, Timo D.
err分享
err收藏
Characteristics predicting the efficacy of SGLT-2 inhibitors versus GLP-1 receptor agonists on major adverse cardiovascular events in type 2 diabetes mellitus: a meta-analysis study
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2023-06-28
err8
errOAAI
errSohn, Minji; Dietrich, Johannes W.; Nauck, Michael A.; Lim, Soo
err分享
err收藏
Gut hormone co-agonists for the treatment of obesity: from bench to bedside
errNATURE METABOLISM
IF20.8
err2023-06-12
err43
PREAI
errNogueiras, Ruben; Nauck, Michael A. A.; Tschoep, Matthias H. H.
err分享
err收藏
CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes
errCARDIOVASCULAR DIABETOLOGY
IF10.6
err2023-03-16
err8
errOAAI
errSchnell, Oliver; Battelino, Tadej; Bergenstal, Richard; Birkenfeld, Andreas L.; Ceriello, Antonio; Cheng, Alice; Davies, Melanie; Edelman, Steve; Forst, Thomas; Giorgino, Francesco; Green, Jennifer; Groop, Per-Henrik; Hadjadj, Samy; Heerspink, Hiddo J. L.; Hompesch, Marcus; Izthak, Baruch; Ji, Linong; Kanumilli, Naresh; Mankovsky, Boris; Mathieu, Chantal; Miszon, Martin; Mustafa, Reem; Nauck, Michael; Pecoits-Filho, Roberto; Pettus, Jeremy; Ranta, Kari; Rodbard, Helena W.; Rossing, Peter; Ryden, Lars; Schumm-Draeger, Petra-Maria; Solomon, Scott D.; Skrha, Jan; Topsever, Pinar; Vilsboll, Tina; Wilding, John; Standl, Eberhard
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
N
Naveed Sattar
H 指数: 204 · 论文数: 2.2K
D
Deepak L. Bhatt
H 指数: 197 · 论文数: 3.7K
J
Jens J. Holst
H 指数: 193 · 论文数: 2.7K
E
Eric D. Peterson
H 指数: 173 · 论文数: 1.9K
S
Stuart Pocock
H 指数: 166 · 论文数: 953
查看更多